A genetic variant of 5-hydroxytryptamine receptor 3C (HTR3C): A novel link to chemotherapy-induced side effects.

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	9630
Pages (from-to)	1
Journal	Journal of Clinical Oncology
Volume	31
Issue number	15 Supplement
State	Published - 2013
Event	ASCO Annual Meeting Proceedings : PATIENT AND SURVIVOR CARE - Duration: 31 May 2013 → 4 Jun 2013 https://meetinglibrary.asco.org/browse-meetings/2013%20ASCO%20Annual%20Meeting

Cite this

@article{4b9fe04a78e94646b10a20fa0ff28645,

title = "A genetic variant of 5-hydroxytryptamine receptor 3C (HTR3C): A novel link to chemotherapy-induced side effects.",

author = "Tami Rubinek and Dorit Pud and Gil Har-Zahav and Zvi Symon and Yael Laitman and Ido Wolf",

year = "2013",

language = "English",

volume = "31",

pages = "1",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "15 Supplement",

note = "ASCO Annual Meeting Proceedings : PATIENT AND SURVIVOR CARE ; Conference date: 31-05-2013 Through 04-06-2013",

url = "https://meetinglibrary.asco.org/browse-meetings/2013\%20ASCO\%20Annual\%20Meeting",

}

TY - JOUR

T1 - A genetic variant of 5-hydroxytryptamine receptor 3C (HTR3C): A novel link to chemotherapy-induced side effects.

AU - Rubinek, Tami

AU - Pud, Dorit

AU - Har-Zahav, Gil

AU - Symon, Zvi

AU - Laitman, Yael

AU - Wolf, Ido

PY - 2013

Y1 - 2013

UR - https://ascopubs.org/doi/abs/10.1200/jco.2013.31.15_suppl.9630

M3 - Meeting Abstract

SN - 0732-183X

VL - 31

SP - 1

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15 Supplement

M1 - 9630

T2 - ASCO Annual Meeting Proceedings

Y2 - 31 May 2013 through 4 June 2013

ER -